Jeffrey Bendix

The increase is expected to be somewhat offset by the impact of biosimilars coming to market and more care being provided in outpatient settings.

The growing availability of direct-to-consumer genetic tests highlights the need for validating and interpreting the tests’ results.

State performance scorecard tracks uninsured kids, access, quality and costs. Often lack of data stalls quality incentives in pediatrics